In this study, the authors organized a nationwide study group comprising high-volume centers throughout Japan to collect patients with very-early-stage pancreatic cancer. They initially performed an open-label study involving 83 cases, with subsequent results showing significant differences after surgical removal in stage 0–IA. Preoperative urine samples had a significantly higher chemotaxis index compared to postoperative samples in patients with pancreatic cancer and healthy volunteers. Read more. . .
Oncotarget published “Scent test using Caenorhabditis elegans to screen for early-stage pancreatic cancer” which reported that although early detection and diagnosis are indispensable for improving the prognosis of patients with pancreatic cancer, both have yet to be achieved. Except for pancreatic cancer, other cancers have already been screened through scent tests using animals or microorganisms, including Caenorhabditis elegant.